
The Indian stock indices gained after a muted open on Tuesday, November 17, as investors focused on buying momentum amid sharp pullback in oil prices in the global market.
as of 21/11/2026, 7:06:18 pm
02/Price history
1 week · 15-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
| 20 Nov 2026 | 1,079.55 | 1,081.00 | 1,079.55 | 1,081.00 | +0.13% | 1.45 | 54.2K |
| 20 Nov 2026 | 1,079.45 | 1,082.50 | 1,076.30 | 1,079.55 | +0.01% | 6.20 | 3.92 L |
| 20 Nov 2026 | 1,080.70 | 1,081.00 | 1,077.90 | 1,079.25 | -0.13% | 3.10 | 1.68 L |
| 20 Nov 2026 | 1,083.80 | 1,084.55 | 1,080.30 | 1,080.70 | -0.29% | 4.25 | 1.35 L |
| 20 Nov 2026 | 1,085.05 | 1,085.80 | 1,082.25 | 1,083.80 | -0.12% | 3.55 | 1.21 L |
| 20 Nov 2026 | 1,087.90 | 1,088.00 | 1,082.75 | 1,085.10 | -0.26% | 5.25 | 1.48 L |
| 20 Nov 2026 | 1,085.55 | 1,088.00 | 1,084.60 | 1,088.00 | +0.23% | 3.40 | 1.45 L |
| 20 Nov 2026 | 1,085.60 | 1,088.80 | 1,085.15 | 1,085.70 | +0.01% | 3.65 | 2.07 L |
| 20 Nov 2026 | 1,080.75 | 1,086.80 | 1,080.55 | 1,085.40 | +0.43% | 6.25 | 1.71 L |
| 20 Nov 2026 | 1,082.50 | 1,083.00 | 1,079.50 | 1,081.05 | -0.13% | 3.50 | 1.35 L |
Historical price and volume data · Showing 1–10 of 125
03/Valuation & returns
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 38%
Price ÷ book value per share
Worse than sector by 204%
Net income ÷ total assets
Better than sector by 75%
Net income ÷ shareholders' equity
Better than sector by 138%
EBIT ÷ capital employed
Better than sector by 11%
Liquid assets ÷ current liabilities
Worse than sector by 97%
Enterprise value ÷ EBITDA
Worse than sector by 74%
04/Business
Sector: Healthcare Services
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, namely Medical and Healthcare Services. It provides a wide array of services, including advanced cardiac care, lung transplants, prostate laser surgery, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services, as well as radiology, imaging, and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 22 healthcare facilities across the Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. It also offers diagnostic services to patients outside its network.
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.
| Revenue | 8,536 | 7,184 | 5,584 | 4,702 |
|---|---|---|---|---|
| Revenue growthreported | 18.8% | 28.6% | 18.8% | — |
| Operating profit | 1,676 | 1,406 | 1,365 | 1,064 |
| Operating profit growthreported | 19.1% | 3.0% | 28.4% | — |
| Operating marginderived | 19.6% | 19.6% | 24.5% | 22.6% |
| Net profit | 1,442 | 1,076 | 1,058 | 1,104 |
| Net profit growthreported | 34.1% | 1.7% | -4.2% | — |
| Net marginderived | 16.9% | 15.0% | 18.9% | 23.5% |
| EPS — basic₹/share, annual | 14.83 | 11.07 | 10.89 | 11.38 |
Figures in ₹ crore. Margin rows are computed from the reported values.
| Revenue | 8,373 | 7,028 | 5,406 | 4,563 |
|---|---|---|---|---|
| Other Income | 163 | 156 | 177 | 139 |
| Total Revenue | 8,536 | 7,184 | 5,583 | 4,702 |
| Total Expenses | 6,812 | 5,704 | 4,218 | 3,638 |
| Profit Before Tax | 1,676 | 1,406 | 1,365 | 1,064 |
| Tax | 233 | 330 | 308 | -40 |
| Profit After Tax | 1,442 | 1,076 | 1,058 | 1,104 |
| EPS - Basic | 14.83 | 11.07 | 10.89 | 11.38 |
| EPS - Diluted | 14.76 | 11.01 | 10.84 | 11.36 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
| Total assets | 17,231 | 15,214 | 12,000 | 10,102 |
|---|---|---|---|---|
| Total liabilities | 6,484 | 5,834 | 3,592 | 2,692 |
| Net worthderived | 10,747 | 9,381 | 8,408 | 7,410 |
| Liabilities ÷ assetsderived | 37.6% | 38.3% | 29.9% | 26.7% |
| Asset growthderived | 13.3% | 26.8% | 18.8% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
| Non-Current Assets | 15,286 | 13,622 | 10,294 | 8,159 |
|---|---|---|---|---|
| Current Assets | 1,945 | 1,593 | 1,706 | 1,943 |
| Total Assets | 17,231 | 15,214 | 12,000 | 10,102 |
| Current Liabilities | 2,187 | 1,806 | 1,249 | 1,046 |
| Net Current Asset | -242 | -214 | 457 | 898 |
| Non-Current Liabilities | 4,297 | 4,027 | 2,343 | 1,647 |
| Equity Capital | 10,747 | 9,381 | 8,408 | 7,410 |
| Total Equity & Liabilities | 17,231 | 15,214 | 12,000 | 10,102 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
| Operating activities | 1,633 | 1,438 | 1,122 | 1,209 |
|---|---|---|---|---|
| Operating changereported | 13.6% | 28.2% | -7.2% | — |
| Investing activities | -1,689 | -1,611 | -1,285 | -1,187 |
| Investing changereported | -4.9% | -25.3% | -8.3% | — |
| Financing activities | 59 | -163 | -264 | -289 |
| Financing changereported | 136.3% | 38.1% | 8.6% | — |
| Net cash flowderived | 4 | -336 | -428 | -266 |
| Free cash flowoperating + investing | -56 | -173 | -164 | 22 |
Figures in ₹ crore.
| Profit before tax | 1,676 | 1,406 | 1,365 | 1,064 |
|---|---|---|---|---|
| Income before WC changes | 2,268 | 1,884 | 1,550 | 1,290 |
| Change in Assets | -369 | -240 | -145 | -40 |
| Change in Liabilities | 106 | 116 | -15 | 121 |
| Change in WC | -263 | -125 | -159 | 81 |
| Cash flow from Operations | 1,633 | 1,438 | 1,122 | 1,209 |
| Cash flow from Investing | -1,689 | -1,611 | -1,285 | -1,187 |
| Cash flow from Financing | 59 | -163 | -264 | -289 |
| Total Cash Flow | 4 | -336 | -428 | -266 |
| Cash (Start of the year) | 662 | 980 | 1,374 | 309 |
| Cash (End of the year) | 666 | 662 | 980 | 43 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
| DividendFinal | ₹2.00 | 20.0% | 03 Jul 2026 | 03 Jul 2026 | 21 May 2026 |
10/Comparison
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B | |
| MOLBIOMolbio Diagnostics Ltd | Healthcare | ₹1,495.50 | -2.02% | 7.01 L | ₹17,228 Cr | $1.91B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Articles published in the last seven days, paginated by the provider.

The Indian stock indices gained after a muted open on Tuesday, November 17, as investors focused on buying momentum amid sharp pullback in oil prices in the global market.

On November 16, the SENSEX gained 512.34 points or 0.63% to close at 82,104.79, while the NIFTY50 surged by 146.80 points or 0.58% to end at 25,291.10.

The broader market, however, underperformed the main equity benchmark indices, with the NIFTY Midcap 100 falling 0.51% while the NIFTY Smallcap 100 declined 1.1%.